According to Sesen Bio 's latest financial reports the company's current revenue (TTM) is $40 M. In 2021 the company made a revenue of $26.54 M an increase over the years 2020 revenue that were of $11.23 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $40 M | 50.69% |
2021 | $26.54 M | 136.24% |
2020 | $11.23 M | |
2019 | N/A | |
2018 | N/A | -100% |
2017 | $0.42 M | -98.58% |
2016 | $29.98 M | 2928.38% |
2015 | $0.99 M | -55.86% |
2014 | $2.24 M | 68.14% |
2013 | $1.33 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |